About JVM
JVM is a company based in Daegu (South Korea) founded in 1977. JVM has raised $112 million across 1 funding round from investors including Hanmi. JVM operates in a competitive market with competitors including Lumere, Medbikri, Maisha Meds, OrbitalRX and Redbook, among others.
- Headquarter Daegu, South Korea
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Jvm Co., Ltd.
-
Annual Revenue
$119.81 M (USD)8.59as on Dec 31, 2025
-
Net Profit
$19.62 M (USD)-1.71as on Dec 31, 2025
-
EBITDA
$23.86 M (USD)2.22as on Dec 31, 2024
-
Total Equity Funding
$112 M (USD)
in 1 rounds
-
Latest Funding Round
$112 M (USD), Series A
Jun 09, 2016
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of JVM
JVM is a publicly listed company on the KRX with ticker symbol 054950 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of JVM
JVM has successfully raised a total of $112M through 1 strategic funding round. The most recent funding activity was a Series A round of $112 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in JVM
JVM has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Hanmi.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
NCEs and generic pharmaceutical products are developed and manufactured.
|
Locked | Locked | Locked |
Investor details for JVM
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by JVM
Investment portfolio details for JVM
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - JVM
Detailed financials for JVM
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Jvm Comparisons
Peer comparison for JVM
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of JVM
JVM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lumere, Medbikri, Maisha Meds, OrbitalRX and Redbook, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of supply chain management and formulary management for pharmacies and healthcare organizations
|
|
| Locked | Locked | Locked |
Inventory and sales management solutions for pharmacies are provided.
|
|
| Locked | Locked | Locked |
Supply chain and inventory management software is provided for pharmacies.
|
|
| Locked | Locked | Locked |
Provider of an online platform for pharmacists to manage drug shortages and supply chain management
|
|
| Locked | Locked | Locked |
GST-enabled software for pharmacy retail and distribution management is provided.
|
Detailed competitors of JVM
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Jvm
Complete news archive for JVM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about JVM
JVM was founded in 1977 and raised its 1st funding round 39 years after it was founded.
JVM is headquartered in Daegu, South Korea.
JVM is a funded company, having raised a total of $112M across 1 funding round to date.
Annual revenue of JVM is $119.81M as on Dec 31, 2025.
Founded in 1977 and headquartered in Daegu, South Korea, JVM operates in the pharmacy automation sector. Solutions for medication dispensing, packaging, and management are delivered, including the OnCube software platform. This software integrates with systems such as ATDPS, STS load stations, and c-cabin for administrative oversight. Features encompass real-time monitoring, inventory control, secure access, and reporting capabilities, supporting pharmacy operations.
Yes, JVM is publicly traded on KRX under the ticker symbol 054950.
JVM has 1 investor. Key investors include Hanmi.
The ticker symbol of JVM is 054950 on KRX.